These are automatic tax-withholding sales tied to RSU vesting, not discretionary insider selling. No bearish signal — monitor for any discretionary insider sales in the next 30 days, which would be more concerning. The stock's strong recent performance (+78% on Aug 15 report) and 89% analyst bullish consensus suggest the fundamental story remains intact.
Price Chart
Executive Summary
Two AMLX officers (James M. Frates and Camille L. Bedrosian) filed Form 144 notices on September 11, 2026, each indicating intent to sell 22,807 shares to cover tax withholding obligations from vesting performance-based restricted stock units. Both sales are described as automatic and non-discretionary, with identical share counts and broker details, suggesting a coordinated, pre-planned tax withholding event rather than a discretionary insider sale. The total proposed sale value is approximately $1.1M based on the prior day's close, which is immaterial relative to the $4.0B market cap and does not signal insider concern about fundamentals.
Key Facts
- Two officers (James M. Frates and Camille L. Bedrosian) each filed Form 144 to sell 22,807 shares of AMLX common stock.
- Sales are to cover tax withholding obligations from vesting performance-based restricted stock units, described as automatic and not at the discretion of the reporting persons.
- Total proposed sale value is approximately $1.1M, representing a negligible fraction of the $4.0B market cap.
- Both filings were made on September 11, 2026, with identical share counts and broker (Morgan Stanley), indicating a coordinated tax-withholding event.
Financial Impact
~$1.1M total proposed sales (22,807 shares × 2 officers at ~$24/share based on prior close), immaterial vs $4.0B market cap
Risk Factors
- If additional discretionary insider sales emerge in the next 30 days, it could signal waning confidence despite the tax-withholding explanation for these filings.
- AMLX is a single-product biotech (AMX0035 for ALS) with binary regulatory/pipeline risk — any negative catalyst could reverse recent gains.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (AMLX) — Batch item 1 | 0001193125-26-389246 |
| Document: 0001193125-26-389246-index.html | 0001193125-26-389245 |
| Document: 0001193125-26-389246.txt | 0001193125-26-389246 |
| 144 Filing (AMLX) — Batch item 4 | 0001193125-26-389245 |
| Document: 0001193125-26-389245-index.html | 0001193125-26-389246 |
| Document: 0001193125-26-389245.txt | 0001193125-26-389246 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 144 | $28.04 | awaiting T+20 | — | $27.09 (−3.39%) |
Sep 14, 2026 6w ago | Insider Cluster | $33.15 $26.85 | ▼ −19.00% | ▼ −21.73% | $27.09 (−18.28%) |
Sep 11, 2026 6w ago | 144 | $33.64 $27.48 | ▼ −18.31% | ▼ −20.57% | $27.09 (−19.47%) |
Aug 18, 2026 9w ago | 8-K | $35.11 $33.05 | ▼ −5.87% | ▼ −4.88% | $27.09 (−22.84%) |
Aug 15, 2026 10w ago | Institutional Cluster | $21.43 $33.15 | ▲ +54.69% | ▲ +56.67% | $27.09 (+26.41%) |
Aug 6, 2026 11w ago | 8-K | $24.19 $33.96 | ▲ +40.39% | ▲ +39.79% | $27.09 (+11.99%) |
Jun 11, 2026 19w ago | Institutional Cluster | $13.91 $18.38 | ▲ +32.14% | ▲ +30.24% | $27.09 (+94.75%) |
Apr 23, 2026 26w ago | DEFA14A | $17.32 $13.61 | ▼ −21.42% | ▼ −26.05% | $27.09 (+56.41%) |
Mar 2, 2026 34w ago | Insider Cluster | $15.30 $12.76 | ▼ −16.60% | ▼ −8.66% | $27.09 (+77.06%) |
Feb 23, 2026 35w ago | Insider Cluster | $13.90 $13.53 | ▲ +2.66% | ▼ −1.28% | $27.09 (−94.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers